Exercise may improve CIPN symptoms in ovarian cancer patients ... Exercise interventions may help manage chemotherapy-induced peripheral neuropathy (CIPN) in patients with ovarian cancer through ...

Artelo Biosciences, Inc (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...

An APP’s research is focused on chemo-induced peripheral neuropathy in Black breast cancer survivors and its impact on their long-term quality of life. Given the significant number of breast cancer ...

The study found that a brain region called the lateral parabrachial nucleus (LPBN) plays a key role in managing this heightened sensitivity.

Artelo Biosciences Inc (NASDAQ:ARTL) completed a safety review of the first cohort of eight healthy volunteers in the company ...

The findings suggest that docetaxel once every three weeks led to significantly less treatment-induced peripheral neuropathy (TIPN) and required fewer dose reductions. While the study did not confirm ...

So treatment to manage your symptoms is important ... can help give you guidance on how to eliminate gluten from your diet. People with peripheral neuropathy induced by celiac disease should consult ...

Jane Street Group LLC bought a new position in shares of MediciNova, Inc. (NASDAQ:MNOV – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & ...

Artelo Biosciences (NASDAQ:ARTL – Get Free Report)‘s stock had its “buy” rating reissued by D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They currently have a $6.00 price ...

APX-3330 is under clinical development by Opus Genetics and currently in Phase II for Non-Proliferative Diabetic Retinopathy (NPDR).